Home/Filings/4/0001179110-19-012360
4//SEC Filing

Sagartz John E 4

Accession 0001179110-19-012360

CIK 0000720154other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:57 PM ET

Size

4.9 KB

Accession

0001179110-19-012360

Insider Transaction Report

Form 4
Period: 2019-12-02
Sagartz John E
DirectorChief Strategy Officer
Transactions
  • Award

    Common Shares

    2019-12-02+8,974630,499 total
Footnotes (2)
  • [F1]Represents restricted grant subject to vesting and forfeiture.
  • [F2]Of the 630,499 shares reported, 617,625 shares were previously reported as indirectly held. These shares were distributed to the reporting person as part of a pro-rata distribution from SW Chrysalis, LLC, of which the reporting person is the Co-President and Chief Strategy Officer.

Issuer

BIOANALYTICAL SYSTEMS INC

CIK 0000720154

Entity typeother

Related Parties

1
  • filerCIK 0001746201

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:57 PM ET
Size
4.9 KB